Nanobiomaterial-based vaccination immunotherapy of cancer
文献类型：期刊论文
| 作者 | Chen, Fangmin1,2; Wang, Yingjie1,2,3; Gao, Jing1,2; Saeed, Madiha1,2; Li, Tianliang1,2; Wang, Weiqi1,2; Yu, Haijun1,2,4
|
| 刊名 | BIOMATERIALS
 |
| 出版日期 | 2021-03-01 |
| 卷号 | 270页码:26 |
| 关键词 | Cancer immunotherapy Nanovaccine Lymph node-targeting Biomimetic nanobiomaterials Antitumor immune response |
| ISSN号 | 0142-9612 |
| DOI | 10.1016/j.biomaterials.2021.120709 |
| 通讯作者 | Yu, Haijun(hjyu@simm.ac.cn) |
| 英文摘要 | Cancer immunotherapies including cancer vaccines, immune checkpoint blockade or chimeric antigen receptor T cells have been exploited as the attractive treatment modalities in recent years. Among these approaches, cancer vaccines that designed to deliver tumor antigens and adjuvants to activate the antigen presenting cells (APCs) and induce antitumor immune responses, have shown significant efficacy in inhibiting tumor growth, preventing tumor relapse and metastasis. Despite the potential of cancer vaccination strategies, the therapeutic outcomes in preclinical trials are failed to promote their clinical translation, which is in part due to their inefficient vaccination cascade of five critical steps: antigen identification, antigen encapsulation, antigen delivery, antigen release and antigen presentation to T cells. In recent years, it has been demonstrated that various nanobiomaterials hold great potential to enhance cancer vaccination cascade and improve their antitumor performance and reduce the off-target effect. We summarize the cutting-edge advances of nanobiomaterials-based vaccination immunotherapy of cancer in this review. The various cancer nanovaccines including antigen peptide/adjuvant-based nanovaccines, nucleic acid-based nanovaccines as well as biomimetic nanobiomaterials-based nanovaccines are discussed in detail. We also provide some challenges and perspectives associated with the clinical translation of cancer nanovaccines. |
| 资助项目 | National Natural Science Foundation of China[32050410287] ; National Natural Science Foundation of China[51873228] ; International Cooperation Project of Science and Technology Commission of Shanghai Municipality[20430711800] ; Youth Innovation Promotion Association of CAS[2014218] ; CAS President's International Fellowship Initiative Program[2019PB0023] ; Postdoctoral Science Foundation of China[2019M661667] ; Shanghai Post-Doctoral Excellence Program[2019116] |
| WOS研究方向 | Engineering ; Materials Science |
| 语种 | 英语 |
| WOS记录号 | WOS:000621194400002 |
| 出版者 | ELSEVIER SCI LTD |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/295584]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Yu, Haijun |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China 3.Univ Sci & Technol China, Nano Sci & Technol Inst, Suzhou 215123, Peoples R China 4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chen, Fangmin,Wang, Yingjie,Gao, Jing,et al. Nanobiomaterial-based vaccination immunotherapy of cancer[J]. BIOMATERIALS,2021,270:26. |
| APA | Chen, Fangmin.,Wang, Yingjie.,Gao, Jing.,Saeed, Madiha.,Li, Tianliang.,...&Yu, Haijun.(2021).Nanobiomaterial-based vaccination immunotherapy of cancer.BIOMATERIALS,270,26. |
| MLA | Chen, Fangmin,et al."Nanobiomaterial-based vaccination immunotherapy of cancer".BIOMATERIALS 270(2021):26. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。